Core Scientific, Inc. designs, builds, and operates large-scale, purpose-built data centers supporting high-density colocation services and digital asset mining. The company serves customers in the United States, providing infrastructure optimized for artificial intelligence, high-performance computing, and other power-intensive workloads. Its business segments include high-density colocation, where it leases space to third parties, and digital asset mining, where it earns assets for its own account. Key partnerships include long-term contracts with CoreWeave for significant leased power capacity. Founded in 2017, the company focuses on converting its data center portfolio to high-density colocation infrastructure while maintaining digital asset mining operations during the transition period.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Building Products & Equipment Homepage corescientific.com
Sector Industrials IR page investors.corescientific.com
Tags
data centers, high-density colocation, digital asset mining, ai infrastructure, high-performance computing, wholesale colocation, power-intensive computing, liquid cooling, cloud infrastructure, enterprise computing, CoreWeave
Press page corescientific.com/resources/newsroom

Metrics

Valuation  
Market cap $ 4.365B
Market cap (USD) $ 4.365B
P/E -4.10
PEG —
P/BV -4.00
P/S 7.37
P/OCF 9.71
P/FCF -3.31
Dividend yield —
Turnover / mcap —
Returns  
ROE 30.0%
ROI -295.8%
ROIC -188.8%
Profit margin -90.5%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock No
Diluting (TTM) Yes
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score -52.9%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue 319.019M 510.672M 502.4M 640.313M 544.483M
Net profit -288.616M -1.315B -246.487M -2.146B -32.499M
Free cash flow -450.75M -52.065M 48.953M -178.793M -56.735M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Share price 14.56 14.05 — 2.68 —
Price performance 12m 0.04 — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) — — 1.38M 234,000 1M 1.03M —
↳ YoY growth -83.1% +327.8% +2.4%
Borrowings, current (USD) — — — — — — 0.00
Borrowings, non-current (USD) — — — — — — 1.06B
Lease liabilities (USD) — — 1.4M 1.49M 57.1M 109M 102M
Cash and deposits (USD) 6.91M 8.72M 970,876 15.9M 50.4M 836M 311M
Intangible assets (USD) — — 8.2M 1.7M 2.25M — 1.08M
Right-of-use assets (USD) — — 6.7M 20.4M 7.84M 114M 108M
Net debt (borrowings + leases - cash) (USD) — — — — — — 851M
Cash flow detail
Operating cash flow (USD) — -23.8M -1.87M 205M 65.1M 42.9M 278M
Purchases of property, plant and equipment (USD) — 0.00 0.00 -384M -16.2M -95M -729M
Purchases of intangible assets (USD) — — — — -833,000 -231,000 -10.2M
Change in receivables (cash effect) (USD) — -1.3M -7.42M -7.86M -767,000 659,000 0.00
Change in payables (cash effect) (USD) — -1.77M 263,119 26.7M 119M -12.3M 10.8M
Share buybacks (cash effect) (USD) — — — -31.6M 0.00 0.00 —
Interest paid (cash effect) (USD) — -2.9M -38.2M -86M -4.71M -28.8M -15.2M
Income taxes paid (cash effect) (USD) — 0.00 -9.62M -5.76M 370,000 159,000 -205,000
Share-based compensation (USD) — 3.04M 0.00 183M 58.9M 51.9M 98.2M
Operating cash flow before change in receivables (USD) — -22.5M -49.3M 213M 65.9M 42.2M 278M
Free cash flow (OCF - PPE - intangibles) (USD) — -23.8M -56.7M -179M 49M -52.1M -461M
Income detail
Research and development expense (USD) — 5.27M 7.67M 27M 7.18M 11.8M —
Total comprehensive income (USD) — -12.2M 36.3M -2.14B -246M -1.32B —
Comprehensive income to owners (USD) — -12.2M 36.3M -2.14B -246M -1.32B —
Provision for credit losses (USD) — 616,000 0.00 9M 0.00 0.00 —
Credit cost ratio (credit losses / average receivables) (%) — — — 1,114.4% 0.0% 0.0% —
Reported Apr 4, 2023 Apr 4, 2023 Apr 4, 2023 Feb 27, 2025 Mar 2, 2026 Mar 2, 2026 Jul 28, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Core Scientific Announces Third Quarter 2026 Results Bull 5 Bear 0 Results

November 05, 2026 7:00 am EST Download as PDF

Related Documents

Earnings WebcastAudio

PresentationPDF

10-QHTML XBRL Zip

MIAMI--(BUSINESS WIRE)-- Core Scientific, Inc. (NASDAQ: CORZ), a leader in digital infrastructure for high-density colocation services (“HDC”), today announced financial results for the third quarter ended September 30, 2026.

“Our execution at scale is translating into results, with a significant sequential increase in GAAP colocation revenue,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “We are nearing full delivery under our first colocation agreement while construction under our second is underway across five campuses. With revenue growing and substantial contracted capacity still to deliver, we have built a strong foundation for our next phase of growth.”

Recent Business Developments

  • Colocation revenue increased nearly 60% sequentially to $215.4 million in the third quarter of 2026, driven by continued delivery of billing megawatts.
  • Billing for 485 MW of capacity as of September 30, 2026, representing over $700 million in average annualized colocation GAAP revenue.
  • Net income increased to $1.2 billion, benefiting from a non-cash gain in the change in fair value of warrants. Adjusted EBITDA more than tripled sequentially to $133.6 million, with margins expanding to 57%, up from 25%.

Financial Summary and Operating Metrics (in millions, except billing megawatts)

Scroll to view ↔

Metric Q3 2026 Q2 2026 Q3 2025
Billing MW 485 395 N/A
Colocation Revenue $215.4 $136.7 $15.0
Total Revenue $232.9 $164.2 $81.1
Gross Profit $123.3 $70.0 $3.9
Net income (loss)(1) $1,178.1 $(1,155.3) $(144.0)
Adjusted EBITDA $133.6 $41.1 $6.5
Capital Expenditures (“CapEx”)(2) $985.1 $797.5 $244.5
Liquidity and DSRA(3) $1,744.2 $2,601.1 $694.8

Scroll to view ↔

(1) Net income (loss) for the quarters ended September 30, 2026 and June 30, 2026 were primarily driven by the change in fair value of warrants, reflecting changes in the Company’s stock price during the periods.
(2) CapEx includes purchases of property, plant and equipment and acquisitions of land and development rights.
(3) Liquidity and DSRA is comprised of cash and cash equivalents, digital assets, revolver availability, and all restricted cash including the debt service reserve accounts. Restricted cash as of September 30, 2026 and June 30, 2026 included funds held in escrow in connection with certain utility and development costs. As of June 30, 2026, restricted cash also included funds held in escrow for the now closed Polaris DS LLC acquisition. There was no restricted cash as of September 30, 2025.

Conference Call and Earnings Presentation

In conjunction with this release, Core Scientific, Inc. will host a conference call today, Thursday, November 5, 2026, at 8:30 am Eastern Time that will be webcast live. Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, and Jon Charbonneau, Senior Vice President, Investor Relations will host the call.

Investors with Internet access may listen to the live audio webcast via the Investor Relations page of the Core Scientific, Inc. website, http://investors.corescientific.com or by using the following link https://event.choruscall.com/mediaframe/webcast.html?webcastid=9RapppQ4

A supplementary investor presentation for the third quarter 2026 may be accessed at https://investors.corescientific.com/news-events/presentations

Audio Replay

An audio replay of the event will be archived on the Investor Relations section of the Company's website at http://investors.corescientific.com .

About Core Scientific

Core Scientific is a leader in designing, building and operating large scale, purpose-built data centers for high-density colocation (“HDC”) services. Core Scientific operates facilities for high-density colocation services serving artificial intelligence-related (“AI”) workloads and is a premier provider of digital infrastructure and services to its third-party customers. The majority of the Company's revenue is derived from high-density colocation services, with the remainder derived from earning digital assets for the Company's own account and from digital asset mining hosting services. The Company is in the process of repurposing its remaining mining facilities to support its high-density colocation services business as circumstances allow. Core Scientific’s facilities are located in Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1) and Texas (4). To learn more, visit www.corescientific.com .

Special Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). Forward-looking statements may include words such as “aim,” “estimate,” “plan,” “project,” “forecast,” “goal,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding projections, estimates and forecasts of revenue, contracted revenue and other financial and performance metrics, projections of market opportunity and expectations, the Company’s ability to scale and grow its business, successfully finance and complete construction of its data centers, source sufficient electrical energy, necessary long lead infrastructure components, supplies and equipment, the expected growth of the Company, the Company’s ability to source and retain talent, and our ability to source and acquire suitable additional land and power. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in Part I. Item 1A. — “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and in the Company’s Quarterly Reports on Form 10-Q. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.

There may be additional risks that the Company could not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release and should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

Scroll to view ↔

Core Scientific, Inc.Condensed Consolidated Balance Sheets(Unaudited, in thousands, except par value)
September 30, 2026 June 30, 2026 December 31, 2025
Assets
Current Assets:
Cash and cash equivalents $ 803,941 $ 1,769,735 $ 311,378
Digital assets 2,690 49,675 222,000
Customer funding receivable 282,659 383,758 337,158
Restricted cash, current portion 201,745 165,745 —
Other current assets 131,115 74,731 25,001
Total Current Assets 1,422,150 2,443,644 895,537
Property, plant and equipment, net 2,630,353 1,774,142 1,293,299
Intangibles, net 737,531 228,625 1,076
Operating lease right-of-use assets 110,503 114,199 108,484
Deferred lease incentive, net of current portion 295,000 — —
Restricted cash, net of current portion 635,858 615,911 —
Other noncurrent assets 104,319 80,972 49,248
Total Assets $ 5,935,714 $ 5,257,493 $ 2,347,644
Liabilities and Stockholders’ Deficit
Current Liabilities:
Accounts payable $ 120,876 $ 112,374 $ 126,106
Accrued expenses 779,520 509,189 511,957
Deferred revenue, current portion 309,065 287,201 127,561
Warrant liabilities, current portion 880,725 1,811,587 —
Other current liabilities 17,028 17,443 15,777
Total Current Liabilities 2,107,214 2,737,794 781,401
Long-term debt 4,302,175 4,297,967 1,060,325
Deferred revenue, net of current portion 264,506 367,242 428,290
Warrant liabilities, net of current portion 238,180 163,683 936,107
Other noncurrent liabilities 115,717 110,163 104,261
Total Liabilities 7,027,792 7,676,849 3,310,384
Commitments and contingencies
Stockholders’ Deficit:
Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025 — — —
Common stock; $0.00001 par value; 10,000,000 shares authorized at September 30, 2026 and December 31, 2025; 321,972 and 314,231 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively 3 3 3
Additional paid-in capital 3,378,990 3,229,842 3,183,960
Accumulated deficit (4,471,071 ) (5,649,201 ) (4,146,703 )
Total Stockholders’ Deficit (1,092,078 ) (2,419,356 ) (962,740 )
Total Liabilities and Stockholders’ Deficit $ 5,935,714 $ 5,257,493 $ 2,347,644
Certain prior year amounts have been reclassified for consistency with the current year presentation.

Scroll to view ↔

Core Scientific, Inc.Condensed Consolidated Statements of Operations(Unaudited, in thousands, except per share amounts)
Three Months Ended Nine Months Ended
September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025
Revenue:
Colocation revenue $ 215,432 $ 136,669 $ 14,951 $ 429,640 $ 34,084
Digital asset self-mining revenue 12,263 21,535 57,438 63,903 187,041
Digital asset hosted mining revenue 5,171 5,997 8,714 18,768 18,131
Total revenue 232,866 164,201 81,103 512,311 239,256
Cost of revenue:
Cost of colocation services 87,059 56,686 11,066 177,363 28,602
Cost of digital asset self-mining 19,755 33,700 59,438 100,644 180,197
Cost of digital asset hosted mining services 2,780 3,771 6,694 10,882 13,314
Total cost of revenue 109,594 94,157 77,198 288,889 222,113
Gross profit 123,272 70,044 3,905 223,422 17,143
Loss (gain) on fair value of digital assets (19,264 ) 9,368 (10,957 ) (3,338 ) (30,066 )
Loss on disposal of property, plant and equipment 5,342 1,273 300 20,253 4,472
Loss on remeasurement of assets held for sale, net 1,518 19,495 — 21,013 —
Impairment of property, plant and equipment — — — 266,488 —
Loss on contract termination — 41,948 — 41,948 —
Colocation organizational and site startup costs 12,932 27,039 16,174 48,636 39,496
Advisor fees 4,839 381 5,785 5,553 7,083
Selling, general and administrative 45,555 49,008 47,395 139,408 124,272
Operating income (loss) 72,350 (78,468 ) (54,792 ) (316,539 ) (128,114 )
Non-operating expenses (income), net:
Loss on debt extinguishment — 5,435 — 5,435 1,377
Interest expense (income), net 35,047 23,833 (821 ) 63,737 (4,193 )
Change in fair value of warrants and contingent value rights (1,034,358 ) 1,045,515 74,864 41,956 363,358
Loss on legal settlements — — 15,075 500 15,504
Other non-operating expenses (income), net 37 152 (8 ) 200 (73 )
Total non-operating expenses (income), net (999,274 ) 1,074,935 89,110 111,828 375,973
Income (loss) before income tax expense (benefit) 1,071,624 (1,153,403 ) (143,902 ) (428,367 ) (504,087 )
Income tax expense (benefit) (106,506 ) 1,907 125 (103,999 ) 488
Net income (loss) $ 1,178,130 $ (1,155,310 ) $ (144,027 ) $ (324,368 ) $ (504,575 )
Net income (loss) per share, basic $ 3.42 $ (3.32 ) $ (0.45 ) $ (0.93 ) $ (1.48 )
Net income (loss) per share, diluted $ 0.47 $ (3.32 ) $ (0.45 ) $ (0.93 ) $ (1.48 )
Weighted average shares outstanding, basic 327,700 325,329 318,562 325,334 317,363
Weighted average shares outstanding, diluted 469,006 325,329 318,562 325,334 317,363
Supplemental information - stock based compensation:
Cost of revenue $ 685 $ 1,283 $ 1,251 $ 2,821 $ 3,574
Colocation organizational and site startup costs 6,584 4,302 7,241 15,110 14,831
Selling, general and administrative 17,916 12,655 21,454 43,255 51,896
Stock-based compensation expense, net of amounts capitalized 25,185 18,240 29,946 61,186 70,301
Capitalized stock-based compensation 57 519 227 1,202 623
Total stock-based compensation cost $ 25,242 $ 18,759 $ 30,173 $ 62,388 $ 70,924
Certain prior year amounts have been reclassified for consistency with the current year presentation.

Scroll to view ↔

Core Scientific, Inc.Condensed Consolidated Statements of Cash Flows(Unaudited, in thousands)
Nine Months Ended September 30,
2026 2025
Cash flows from Operating Activities:
Net loss $ (324,368 ) $ (504,575 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization 50,133 54,816
Loss on disposal of property, plant and equipment 20,253 4,472
Loss on remeasurement of assets held for sale, net 21,013 —
Impairment of property, plant and equipment 266,488 —
Change in operating lease right-of-use assets 10,046 8,248
Stock-based compensation 61,186 70,301
Digital asset self-mining revenue (63,903 ) (187,396 )
Proceeds from sales of digital assets generated by self-mining revenue(1) 286,765 —
Gain on fair value of digital assets (3,338 ) (30,066 )
Change in fair value of warrants and contingent value rights 41,956 363,358
Loss on debt extinguishment 5,435 1,377
Deferred income taxes (105,816 ) —
Accrued interest capitalized to construction in progress (23,273 ) —
Changes in operating assets and liabilities:
Customer funding receivable 54,499 (335,643 )
Accounts payable (82,177 ) 105,615
Accrued expenses 167,124 244,977
Deferred revenue from colocation services 19,151 323,796
Other current assets (50,979 ) 11,500
Other operating assets and liabilities, net (53,952 ) (10,040 )
Net cash provided by operating activities 296,243 120,740
Cash flows from Investing Activities:
Purchases of property, plant and equipment (1,494,979 ) (449,752 )
Proceeds from sales of property, plant and equipment 6,094 1,929
Cash paid for asset acquisitions (676,881 ) —
Other investing activities (149 ) (15,160 )
Net cash used in investing activities (2,165,915 ) (462,983 )
Cash flows from Financing Activities:
Debt extinguishment payments (1,000,000 ) (26,862 )
Proceeds from the issuance of debt 4,275,250 —
Debt issuance costs (50,907 ) —
Taxes paid related to net share settlement of equity awards (35,152 ) (5,893 )
Principal payments on debt — (8,613 )
Proceeds from exercise of warrants 11,742 1,746
Other financing activities (1,095 ) (1,672 )
Net cash provided by (used in) financing activities 3,199,838 (41,294 )
Net increase (decrease) in cash, cash equivalents and restricted cash 1,330,166 (383,537 )
Cash, cash equivalents and restricted cash—beginning of period 311,378 836,980
Cash, cash equivalents and restricted cash—end of period $ 1,641,544 $ 453,443
Supplemental disclosures of other cash flow information:
Cash paid for interest, net of capitalized interest $ 19,313 $ 15,285
Income tax payments 640 $ 298
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property, plant and equipment in accounts payable and accrued expenses $ 429,937 $ 154,440
Reclass of property, plant and equipment to held for sale $ 51,262 $ —
Operating lease right-of-use assets obtained in exchange for lease obligations $ 13,440 $ 2,154
Non-cash exercise of warrants $ 1,514 $ 24,692
Liabilities assumed in acquisition $ 115,790 $ —
Issuance of warrants $ 296,423 $ —
Interest capitalized to construction in progress $ 25,828 $ —
Reconciliation of cash, cash equivalents and restricted cash within the Condensed Consolidated Balance Sheets to the amounts shown in the Condensed Consolidated Statements of Cash Flows above:
Cash and cash equivalents $ 803,941 $ 453,443
Restricted cash, current portion 201,745 —
Restricted cash, net of current portion 635,858 —
Total cash, cash equivalents and restricted cash $ 1,641,544 $ 453,443

Scroll to view ↔

(1) Proceeds from digital assets received as noncash revenue consideration liquidated at management's discretion.
Certain prior year amounts have been reclassified for consistency with the current year presentation.

Scroll to view ↔

Core Scientific, Inc.Segment Results(Unaudited, in thousands, except percentages)
Three Months Ended Nine Months Ended
September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025
Colocation Segment
Colocation revenue:
License fees $ 157,265 $ 98,812 $ 9,848 $ 315,272 $ 22,853
Power fees passed through to customer 57,556 35,073 3,553 113,689 9,603
Maintenance and other 611 2,784 1,550 679 1,628
Total colocation revenue 215,432 136,669 14,951 429,640 34,084
Cost of colocation services:
Power fees passed through to customer 57,556 35,073 3,553 113,689 9,604
Depreciation expense 10,061 4,621 219 16,757 389
Employee compensation 6,419 4,801 2,209 14,206 4,651
Facility operations expense 10,371 10,381 4,383 27,507 12,570
Other segment items(1) 2,652 1,810 702 5,204 1,388
Total cost of colocation services 87,059 56,686 11,066 177,363 28,602
Colocation gross profit $ 128,373 $ 79,983 $ 3,885 $ 252,277 $ 5,482
Colocation gross margin 60 % 59 % 26 % 59 % 16 %
Digital Asset Self-Mining Segment
Digital asset self-mining revenue $ 12,263 21,535 $ 57,438 $ 63,903 $ 187,041
Cost of digital asset self-mining:
Power fees 10,483 17,861 33,280 55,614 94,319
Depreciation expense 7,173 9,897 15,474 30,978 52,792
Employee compensation 1,255 4,052 7,803 8,834 23,411
Facility operations expense 636 1,286 2,089 3,895 7,458
Other segment items(1) 208 604 792 1,323 2,217
Total cost of digital asset self-mining 19,755 33,700 59,438 100,644 180,197
Digital Asset Self-Mining gross profit $ (7,492 ) $ (12,165 ) $ (2,000 ) $ (36,741 ) $ 6,844
Digital Asset Self-Mining gross margin (61 )% (56 )% (3 )% (57 )% 4 %
Digital Asset Hosted Mining Segment
Digital asset hosted mining revenue from customers $ 5,171 5,997 $ 8,714 $ 18,768 $ 18,131
Cost of digital asset hosted mining services:
Power fees 1,987 2,356 4,793 7,646 9,367
Depreciation expense 401 626 376 1,332 856
Employee compensation 233 542 1,115 1,202 2,225
Facility operations expense 119 167 297 520 665
Other segment items(1) 40 80 113 182 201
Total cost of digital asset hosted mining services 2,780 3,771 6,694 10,882 13,314
Digital Asset Hosted Mining gross profit $ 2,391 $ 2,226 $ 2,020 $ 7,886 $ 4,817
Digital Asset Hosted Mining gross margin 46 % 37 % 23 % 42 % 27 %
Consolidated
Consolidated total revenue $ 232,866 $ 164,201 $ 81,103 $ 512,311 $ 239,256
Consolidated cost of revenue $ 109,594 $ 94,157 $ 77,198 $ 288,889 $ 222,113
Consolidated gross profit $ 123,272 $ 70,044 $ 3,905 $ 223,422 $ 17,143
Consolidated gross margin 53 % 43 % 5 % 44 % 7 %

Scroll to view ↔

(1) Other segment items consist primarily of software and IT costs, travel, professional and contract services, and telecommunications costs.

**Core Scientific, Inc.
****Non-GAAP Financial Measures
**(Unaudited)

Adjusted EBITDA is a non-GAAP financial measure defined as our net loss, adjusted to eliminate the effect of (i) interest expense (income), net; (ii) provision for income taxes; (iii) depreciation and amortization; (iv) stock-based compensation expense; (v) loss on disposal and impairment of property, plant and equipment; (vi) loss on remeasurement of assets held for sale; (vii) loss on contract termination; (viii) colocation organizational startup costs primarily related to the initial ramp up of new colocation sits and the conversion of existing facilities to colocation data center operations; (ix) loss on debt extinguishment; (x) change in fair value of warrant and contingent value rights; (xi) loss on legal settlements; (xii) post-emergence bankruptcy advisory costs incurred related to reorganization and (xiii) certain additional non-cash items that do not reflect the performance of our ongoing business operations. For additional information, including the reconciliation of net loss to Adjusted EBITDA, please refer to the table below. We believe Adjusted EBITDA is an important measure because it allows management, investors, and our Board of Directors to evaluate and compare our operating results, including our return on capital and operating efficiencies, from period-to-period by making the adjustments described above. In addition, it provides useful information to investors and others in understanding and evaluating our results of operations, as well as provides a useful measure for period-to-period comparisons of our business, as it removes the effect of net interest expense, taxes, certain non-cash items, variable charges and timing differences. Moreover, we have included Adjusted EBITDA in this earnings release because it is a key measurement used by our management internally to make operating decisions, including those related to operating expenses, evaluate performance, and perform strategic and financial planning.

The above items are excluded from our Adjusted EBITDA measure because these items are non-cash in nature or because the amount and timing of these items are not related to the current results of our core business operations which renders evaluation of our current performance, comparisons of performance between periods and comparisons of our current performance with our competitors less meaningful. However, you should be aware that when evaluating Adjusted EBITDA, we may incur future expenses similar to those excluded when calculating this measure. Our presentation of this measure should not be construed as an inference that its future results will be unaffected by unusual items. Further, this non-GAAP financial measure should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). We compensate for these limitations by relying primarily on GAAP results and using Adjusted EBITDA on a supplemental basis. Our computation of Adjusted EBITDA may not be comparable to other similarly titled measures computed by other companies because not all companies calculate this measure in the same fashion. You should review the reconciliation of net loss to Adjusted EBITDA below and not rely on any single financial measure to evaluate our business.

The following table reconciles the non-GAAP financial measure to the most directly comparable U.S. GAAP financial performance measure, which is net loss, for the periods presented (in thousands):

Scroll to view ↔

Three Months Ended Nine Months Ended
September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025
Adjusted EBITDA
Net income (loss) $ 1,178,130 $ (1,155,310 ) $ (144,027 ) $ (324,368 ) $ (504,575 )
Adjustments:
Interest expense (income), net 35,047 23,833 (821 ) 63,737 (4,193 )
Income tax expense (benefit) (106,506 ) 1,907 125 (103,999 ) 488
Depreciation and amortization 17,987 15,498 16,329 50,133 54,816
Stock-based compensation expense 18,601 13,938 22,705 46,076 55,470
Loss on disposal of property, plant and equipment 5,342 1,273 300 20,253 4,472
Loss on remeasurement of assets held for sale, net 1,518 19,495 — 21,013 —
Impairment of property, plant and equipment — — — 266,488 —
Colocation organizational and site startup costs(1) 12,932 27,039 16,174 48,636 39,496
Loss on contract termination — 41,948 — 41,948 —
Loss on debt extinguishment — 5,435 — 5,435 1,377
Change in fair value of warrants and contingent value rights (1,034,358 ) 1,045,515 74,864 41,956 363,358
Loss on legal settlements — — 15,075 500 15,504
Post-emergence bankruptcy advisory costs(2) 29 397 278 743 1,576
Merger transaction advisor fees(2) 4,809 (16 ) 5,507 4,809 5,507
Other 37 151 (8 ) 200 (73 )
Adjusted EBITDA $ 133,568 $ 41,103 $ 6,501 $ 183,560 $ 33,223

Scroll to view ↔

(1) Included in Colocation organizational and site startup costs are costs associated to Stock-based compensation expense of $6.6 million, $4.3 million, and $7.2 million for the three months ended September 30, 2026, June 30, 2026, and September 30, 2025, respectively, and $15.1 million and $14.8 million for the nine months ended September 30, 2026 and 2025, respectively. For the nine months ended September 30, 2025, there was also $4.4 million in site conversion demolition costs.
(2) Included in Advisor fees on the condensed consolidated statements of operations.

Term Library

Scroll to view ↔

Term (MW) Definition How management uses it
Gross Utility Power Capacity Total electric utility power capacity agreements associated with our data center sites under our control as of period end, including capacity that is commissioned for future use. Used for portfolio planning and utility power allocation discussions.
Total Leasable Customer Power Capacity Our estimate of the total non-redundant customer IT load that our data center sites could support in the aggregate as of period end, regardless of whether such capacity has been contracted with customers or remains available for sale. This metric is representative of the amount of power available for customer use in servicing their workloads. Used to assess total customer usable IT load available for leasing, evaluate leased versus unleased capacity, and plan conversion/development sequencing and sales capacity.
Leased Customer Power Capacity Power capacity that is committed to customers under executed customer contracts, regardless of whether service has commenced as of period end. Used to monitor signed customer commitments and contracted backlog and to plan future deployment/commissioning requirements.
Unleased Customer Power Capacity The portion of Total Leasable Customer Power Capacity not committed under customer contracts as of period end. This metric is calculated as Total Leasable Customer Power Capacity minus Leased Customer Power Capacity. Used to monitor remaining uncommitted customer IT load and to prioritize incremental contracting and conversion/commissioning plans.
Billable Customer Power Capacity Portion of Leased Customer Power Capacity for which service has commenced, and we are actively billing as of period end. Used to monitor in-service customer power that is billing and to track deployment/commissioning pace and near-term revenue ramp.

Please follow us on:

https://www.linkedin.com/company/corescientific/

https://twitter.com/core_scientific

https://www.youtube.com/@Core_Scientific

View source version on businesswire.com: https://www.businesswire.com/news/home/20261105707046/en/

Investors:
[email protected]

Media:
[email protected]

Source: Core Scientific, Inc.

Released November 5, 2026

©2026 Core Scientific, Inc. All Rights Reserved.

Market Data copyright © 2026 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia . Terms of Use .

October 15, 2026 7:00 am EDT Download as PDF

MIAMI--(BUSINESS WIRE)-- Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation (“HDC”), today announced it will release its third quarter 2026 financial results prior to financial markets open on Thursday, November 5, 2026. Management will host a conference call and live audio webcast to discuss the results at 8:30 a.m. Eastern Time.

Hosting the call and webcast to review results for the third quarter 2026 will be Adam Sullivan, Chief Executive Officer, Jim Nygaard, Chief Financial Officer, Matt Brown, Chief Operating Officer and Jon Charbonneau, Senior Vice President, Investor Relations.

**Conference Call and Webcast Event Summary
**Date: November 5, 2026
Time: 8:30 a.m. ET

Investors with Internet access may listen to the live audio webcast directly by clicking here or via the Investors section of the Core Scientific, Inc. website, https://investors.corescientific.com .

**Audio Replay Options
**An audio replay of the event will be archived on the Investor Relations section of the Company’s website at https://investors.corescientific.com .

About Core Scientific, Inc.

Core Scientific is a leader in designing, building and operating large scale, purpose-built data centers for high-density colocation (“HDC”) services. Core Scientific operates facilities for high-density colocation services serving artificial intelligence-related (“AI”) workloads and is a premier provider of digital infrastructure and services to its third-party customers. The majority of the Company's revenue is derived from high-density colocation services, with the remainder derived from earning digital assets for the Company's own account and from digital asset mining hosting services. The Company is in the process of repurposing its remaining mining facilities to support its high-density colocation services business as circumstances allow. Core Scientific’s facilities are located in Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1) and Texas (4). To learn more, visit www.corescientific.com .

**Please follow us on:
**https://www.linkedin.com/company/corescientific/

https://twitter.com/core_scientific

https://www.youtube.com/@Core_Scientific

View source version on businesswire.com: https://www.businesswire.com/news/home/20261014599891/en/

Investors:
[email protected]

Media:
[email protected]

Source: Core Scientific, Inc.

Released October 15, 2026

©2026 Core Scientific, Inc. All Rights Reserved.

Market Data copyright © 2026 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia . Terms of Use .

September 25, 2026 7:00 am EDT Download as PDF

Data center executive brings more than two decades of customer relationship experience

MIAMI--(BUSINESS WIRE)-- Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation (“HDC”), today announced that Jay Elms has joined the Company’s executive team as Chief Commercial Officer.

In this role, Elms will be responsible for growing customer relationships and overseeing the customer experience from initial engagement through deployment.

“We are excited to welcome Jay to our executive team,” said Adam Sullivan, Chief Executive Officer of Core Scientific. “Jay joins Core Scientific at an important moment as we enter our next phase of growth. His deep customer relationship experience in the data center industry will be instrumental in ensuring the success of our existing customers while aligning our commercial strategy with our site selection, development and construction capabilities.”

Elms brings more than two decades of sales and commercial leadership experience. Most recently, he served as Senior Vice President of Global Sales at CyrusOne. Before joining CyrusOne, he spent nearly seven years as Vice President of Global Sales at NTT Global Data Centers Americas, where he led commercial engagements with hyperscale and wholesale customers. Earlier in his career, Elms held sales leadership roles at View, Schneider Electric and Siemens. He holds an MBA in Finance from the SMU Cox School of Business and a bachelor’s degree in construction science from Texas A&M University.

“Core Scientific has distinguished itself by delivering complex, AI-ready digital infrastructure at scale,” said Elms. “The Company combines a strong power portfolio with the development and operational capabilities customers need to bring critical infrastructure online. I look forward to scaling customer relationships and enhancing the customer experience.”

About Core Scientific, Inc.

Core Scientific is a leader in designing, building and operating large scale, purpose-built data centers for high-density colocation (“HDC”) services. Core Scientific operates facilities for high-density colocation services serving artificial intelligence-related (“AI”) workloads and is a premier provider of digital infrastructure and services to its third-party customers. The majority of the Company's revenue is derived from high-density colocation services, with the remainder derived from earning digital assets for the Company's own account and from digital asset mining hosting services. The Company is in the process of repurposing its remaining mining facilities to support its high-density colocation services business as circumstances allow. Core Scientific’s facilities are located in Alabama (1), Georgia (2), Kentucky (1), North Carolina (1), North Dakota (1), Oklahoma (1) and Texas (4). To learn more, visit www.corescientific.com .

Special Note Regarding Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended, (the “Exchange Act”). Forward-looking statements may include words such as “aim,” “estimate,” “plan,” “project,” “forecast,” “goal,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding the Company’s senior secured credit facilities, including the anticipated use of proceeds therefrom and the impact on the Company’s capital efficiency and financial flexibility. These statements are provided for illustrative purposes only and are based on various assumptions, whether or not identified in this press release, and on the current expectations of the Company’s management. These forward-looking statements are not intended to serve, and must not be relied on by any investor, as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of the Company.

These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, known or unknown, that could cause actual results to vary materially from those indicated or anticipated. These risks, assumptions and uncertainties include those described in the section titled “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, Quarterly Reports on Form 10-Q, and the Company’s other filings with the Securities and Exchange Commission. If one or more of these risks or uncertainties materializes, or if underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.

There may be additional risks that the Company could not presently know or that the Company currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect the Company’s expectations, plans or forecasts of future events and views as of the date of this press release and should not be relied upon as representing the Company’s assessments as of any date subsequent to the date of this press release. The Company anticipates that subsequent events and developments will cause the Company’s assessments to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. Accordingly, you should not place undue reliance on these forward-looking statements, which speak only as of the date they are made.

Please follow us on:

https://www.linkedin.com/company/corescientific/

https://twitter.com/core_scientific

https://www.youtube.com/@Core_Scientific

View source version on businesswire.com: https://www.businesswire.com/news/home/20260925843158/en/

Investors:
[email protected]

Media:
[email protected]

Source: Core Scientific, Inc.

Released September 25, 2026

©2026 Core Scientific, Inc. All Rights Reserved.

Market Data copyright © 2026 QuoteMedia . Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia . Terms of Use .

Prompts

Core Scientific, Inc. (ticker CORZ), listed in United States.

Company History

Date Change Detail
Sep 13, 2021 Renamed POWER & DIGITAL INFRASTRUCTURE ACQUISITION CORP. → CORE SCIENTIFIC, INC./TX
— Former tickers CORZQ

ETFs Holding Core Scientific, Inc.

ETF Weight in ETF Shares Market value As of
NODE 3.95% 112,293 $ 2.874M Jun 30, 2026
LFGY 3.74% 152,443 $ 2.07M Nov 17, 2026
BLOK 3.52% 1,600,317 $ 40.952M Jun 30, 2026
TEKX 2.97% 24,169 $ 328.215K Nov 16, 2026
WGMI 2.83% 380,453 $ 9.736M Jun 30, 2026
CEPI 1.93% 102,730 $ 2.129M Jul 31, 2026
HYP 1.13% 30,532 $ 781.314K Jun 30, 2026
HECO 0.90% 39,593 $ 537.673K Nov 16, 2026
GTEK 0.89% 129,999 $ 2.119M Aug 31, 2026
TCAI 0.74% 103,820 $ 1.692M Aug 31, 2026
JSML 0.69% 120,812 $ 2.503M Jul 31, 2026
JSMD 0.57% 289,220 $ 5.993M Jul 31, 2026
CLSE short -0.39% -215,956 $ -3.52M Aug 31, 2026
AIPO 0.31% 168,542 $ 2.424M Nov 13, 2026
SCDS 0.22% 1,469 $ 19.846K Nov 17, 2026
SYZ 0.15% 3,937 $ 100.748K Jun 30, 2026
VFMO 0.11% 129,579 $ 2.112M Aug 31, 2026
MSSM 0.03% 12,230 $ 199.349K Aug 31, 2026
AVUQ 0.00% 1,453 $ 19.732K Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
CORZ canonical Common share — US nasdaq 13.56 USD 2026-11-16
CORZW Warrant — US nasdaq 9.28 USD 2026-09-30
CORZZ Warrant — US nasdaq 16.14 USD 2026-09-30